Predictors of complications and learning curve using the Angio-SealTM closure device following interventional and diagnostic catheterization

Warren, Benjamin S.; Warren, Stafford G.; Miller, Scott D.

doi:10.1002/(sici)1522-726x(199910)48:2<162::aid-ccd8>3.0.co;2-2

Cited by 65 publications

(45 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The Angio-Seal has been shown to allow earlier ambulatory activity and reduce hospitalization to less than 24 h. 6 This device is simple to use after a suitable training period, although if incorrectly employed, problems such as embolization, infection, or thrombosis may occur. 4,[8][9][10][11][12] The impossibility of arterial access prompted us to use a transprosthetic access and the highly positive experience with the Angio-Seal persuaded us to employ this device in prosthetic surgery, even though this application has not been described. To our knowledge, this is the first report of using the Angio-Seal to achieve closure of the femoral prosthetic puncture site.…”

Section: Discussionmentioning

confidence: 99%

Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases

et al. 2004

View full text Add to dashboard Cite

At least 10% of patients who undergo bilateral aortofemoral bypass are at risk of needing a reoperation for late prosthetic thrombosis because of reduced outflow as the disease progresses. To prevent occlusion of the prostheses, we performed endovascular surgery with transprosthetic access for distal stenosis. We report our experience of using the Angio-Seal with transprosthetic access after angioplasty in three patients who had undergone bilateral aortofemoral bypass. Hemostasis was achieved in all three patients. There were no complications, such as hemorrhage, hematoma, or prosthetic infection, and all three patients were discharged within 24 h. At the 12-, 15-, and 24-month follow-up, none of the patients had any sign of recurrent claudication. Using the Angio-Seal in bilateral aortofemoral bypass provided the means of treating distal stenosis by endovascular surgery with transprosthetic access. This method is both rapid and safe, and may broaden the indications for the endovascular treatment of distal arteriopathies in patients with vascular prostheses.

show abstract

Section: Discussionmentioning

confidence: 99%

Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases

et al. 2004

View full text Add to dashboard Cite

show abstract

“…Favorable outcomes with respect to access sites after fibrinolysis may reflect this extensive experience, as evident from results typified by a "learning curve" [24]. Attempts to control for baseline differences between primary PCI and PCI early after thrombolysis led to our use of a registry design with a plan to determine independent predictors of an increased risk of bleeding [13,[25][26][27].…”

Section: Study Limitationsmentioning

confidence: 99%

Bleeding Complications After Contemporary Pharmacoinvasive Therapy for ST Elevation Myocardial Infarction

Gutierrez

Aggarwal

Gilbert

et al. 2004

J Thromb Thrombolysis

View full text Add to dashboard Cite

show abstract

“…Die Komplikationsrate unter manueller Kompression ist akzeptabel niedrig (zwischen 0,3 und 1,0%) mit höheren Raten bei komplexen Interventionen (3,0%). Die Komplikationsrate wird beeinflusst von verschiedenen Faktoren: höheres Lebensalter (> 65 Jahre), Übergewicht mit einem BMI > 28, Heparindosis und Heparin nach PCI, fibrinolytische Therapie, Größe der arteriellen Schleuse, paVK, u.a [7]. Ein Verschluss der Punktionsstelle im Katheterlabor ohne Druckverband wird von den meisten Patienten als sehr angenehm empfunden.…”

Section: Standards In Interventional Therapy Of Coronary Artery Diseaseunclassified

Standards in der interventionellen Therapie der koronaren Herzkrankheit

Rutsch¹,

Gliech²,

Dübel³

et al. 2002

Herz

View full text Add to dashboard Cite

This review provides an overview of current percutaneous coronary interventional techniques (PCI) in patients with acute and chronic coronary artery disease. The indications for PCI have expanded during the past two decades, and no absolute contraindications remain. The chief limitations to event free survival following balloon angioplasty have been abrupt vessel closure in the short term and restenosis in the long term. The therapeutic effect of arterial vessel enlargement through PCI is accompanied by various degrees of arterial injury with exposure of thrombogenic components. Depending on the degree of activation of the coagulation cascade, as well as platelet adhesion and aggregation, this may result in intracoronary thrombus formation and subsequent ischemic sequelae. Therefore, inhibition of platelets and the coagulation system has always been central to interventional investigations. Restenosis has been the most important long-term limitation of PCI. Coronary artery stents have become an important adjunct to conventional balloon angioplasty owing to their dual function of reducing acute complications and the long term risk of restenosis. Although coronary artery stents serve as antirestenosis devices and reduce target vessel revascularisation requirements compared with balloon angioplasty, they themselves become a source of restenosis. In-stent restenosis is a major challenge for the interventionalist. None of the available interventional modalities provides optimal acute results, and long-term results are even poorer. This is especially true for diffuse in-stent restenosis lesions which have high recurrence rates. Thus, mechanical treatment modalities for evolved in-stent restenosis can only be one step in a comprehensive strategy for prevention and treatment. Brachytherapy as an adjunct seems to be especially promising, but late thrombosis, delayed restenosis and the potential for very late fibrosis are matters of concern. As attention has turned towards the prevention of in-stent restenosis new techniques such as drug delivering stents and gene therapy to inhibit the biological reaction of the vessel wall are likely to obtain greater importance.

show abstract

Predictors of complications and learning curve using the Angio-SealTM closure device following interventional and diagnostic catheterization

Cited by 65 publications

References 8 publications

Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases

Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases

Bleeding Complications After Contemporary Pharmacoinvasive Therapy for ST Elevation Myocardial Infarction

Standards in der interventionellen Therapie der koronaren Herzkrankheit

Contact Info

Product

Resources

About